chrisvoncsefalvay/vaers-outcomes huggingface dataset:
3" plus diameter around injection site of raised, red skin. Area is hot to the touch. Extreme soreness around area. Will treat with ice packs and ibuprofen.
Onset of Bell's Palsy starting on Friday 12-17-2021, seen by 911 Emergency around 9pm to rule out Stroke. Over 48 hrs full paralysis of right side of face, to include movement of Eye lid.
My left deltoid was very red, swollen and hot to the touch. The swelling and redness continued passed 48 hours. My hip joints hurt where I was not able to sleep or go for walks Monday - Wednesday. Tuesday evening (6/8/2021), I started experiencing left chest tightness, near my clavicle/sternum. I would get winded and felt the chest tightness while walking, especially up stairs. My head needed to remain upright because any movement resulted in very painful throbbing near the occipital lobe and upper neck. I felt fatigued and experience brain fog.   I called the respiratory, COVID hotline through the  Clinic and he advised me to be seen immediately. I went to (because we were out of town)
This spontaneous report as received from a pharmacist refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not provided. On 11-OCT-2017, the patient was vaccinated with the first dose of ZOSTAVAX lot # N021172, reconstituted with sterile diluent, for prophylaxis. Thereafter on 19-OCT-2017, the patient also received a dose of ZOSTAVAX reconstituted with sterile diluent, for prophylaxis. No adverse effects were reported.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 06-NOV-2015 the patient was vaccinated with an improperly stored dose of GARDASIL single-dose vial (SDV) (lot # L010596, expiration date 06-APR-2017; dose and route were not reported). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree) and the type of excursion (R/F) were 208, 34 and R. The storage criteria was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
miscarriage when she became sick from the first vaccine; became sick from the first vaccine; Maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of ABORTION SPONTANEOUS (miscarriage when she became sick from the first vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced ABORTION SPONTANEOUS (miscarriage when she became sick from the first vaccine) (seriousness criterion medically significant), ILLNESS (became sick from the first vaccine) and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). At the time of the report, ABORTION SPONTANEOUS (miscarriage when she became sick from the first vaccine) and ILLNESS (became sick from the first vaccine) outcome was unknown and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.  This case concerns of a  female patient  with  no age and  no relevant medical history reported  who experienced the unexpected events of spontaneous abortion, illness and Maternal Exposure during pregnancy. The occurrence of these events are unknown as well as the time to onset  from the vaccine administration with Moderna  since the date of the first dose of the vaccine is also unknown.  Other details of the pregnancy was also not reported like the LMP and EDD. The benefit-risk relationship of Spikevax is not affected by this report.; Sender's Comments: This case concerns of a  female patient  with  no age and  no relevant medical history reported  who experienced the unexpected events of spontaneous abortion, illness and Maternal Exposure during pregnancy. The occurrence of these events are unknown as well as the time to onset  from the vaccine administration with Moderna  since the date of the first dose of the vaccine is also unknown.  Other details of the pregnancy was also not reported like the LMP and EDD. The benefit-risk relationship of Spikevax is not affected by this report.
Uticarial rash all over body, erythematous, small papules, no scratching noted. Diagnosed as hives started on back and spread to rest of body on 11/29. New oral med was introduced to child on 11/28: ORAJEL. No fever mo vomiting no diarrhea.
My symptoms began five days after dose 3.  I developed a rash that was extremely itchy.  When I scratch my skin, I developed hives.  My skin would turn purple.  I saw my doctor and I was prescribed steroids, and this helped.  I was off work for four days due to this side effect.  I no longer have the rash but if I scratch my skin the hives reappear.  I consulted with two specialists: dermatologist and endocrinologist.  They were unable to diagnose anything.
After experiencing left supraclavicular lymph node pain for a few days, on 3/8 I woke up with a noticeable goiter and severs left neck/throat pain.  Swallowing was painful, and my neck ached only on the left side.  I went to an urgent care center after work that day and was told to see my PCP.  I was able to see her on 3/10, and had thyroid labs drawn and a thyroid ultrasound.  The ultrasound showed two nodules > 3.5mm, one on each side of my thyroid.  The left nodule was larger.  I went for more labs on 3/17, and within two days I began experiencing tachycardia, tremors, anxiety, agitation, and palpitations.  I was referred to an endocrinologist and saw her on 3/24.  She prescribed me atenolol, which eliminated my symptoms.  On 4/1 I underwent a radioactive nucleotide reuptake exam and was diagnosed with thyroiditis.  I took the atenolol for about a month and had more labs drawn, which showed I was now hypothroidotic.  I was taken off of the atenolol and started on levothyroxin 50mg qd.  After taking that for two months I had repeat labs that were on the high side of normal, and my dose of levothyroxin was increased slightly.  I am scheduled for a follow-up thyroid ultrasound in two weeks.
My husband and I had some of what I would consider to be minor reactions to our Moderna Covid-19 vaccine; Patient felt tired; The patient saw Dermatologist and the Dermatologist said that the condition was Covid elbow; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (My husband and I had some of what I would consider to be minor reactions to our Moderna Covid-19 vaccine), FATIGUE (Patient felt tired) and COVID-19 (The patient saw Dermatologist and the Dermatologist said that the condition was Covid elbow) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 prophylaxis.     No Medical History information was reported.  On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (My husband and I had some of what I would consider to be minor reactions to our Moderna Covid-19 vaccine), FATIGUE (Patient felt tired) and COVID-19 (The patient saw Dermatologist and the Dermatologist said that the condition was Covid elbow). At the time of the report, IMMUNISATION REACTION (My husband and I had some of what I would consider to be minor reactions to our Moderna Covid-19 vaccine), FATIGUE (Patient felt tired) and COVID-19 (The patient saw Dermatologist and the Dermatologist said that the condition was Covid elbow) outcome was unknown.     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  On an unknown date, the patient saw Dermatologist and the Dermatologist said that the condition was Covid elbow, patient is not sure which shot this occurred after.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-734586 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-734586:Bivalent case (Monovalent MOD-2023-734866) (Same patient)
This case was reported by a healthcare professional and described the occurrence of injection site pain in an adult female subject who was vaccinated with influenza virus vaccine (Fluarix, GlaxoSmithKline) for prophylaxis. The subject received influenza virus vaccine in previous years with no subsequent adverse events. On 07, December 2006 the subject received unspecified dose of Fluarix, On an unspecified date in December 2006, within one week after vaccination with Fluarix, the subject experience injection site pain. At the time of initial reporting, 18, December 2006, the event was ongoing and the healthcare professional reported that the injection site pain, "has lasted for a week" The healthcare professional considered the event was probably related to vaccination with Fluarix.
Patient with history of chilhood seizure.  Seizure free since 4 years of age. Patient had vaso-vagal episode briefly lost consciousness and had 5 to 6 seconds of clonic-tonic jerking arms and legs. Patient had post-ictal state for 2 hrs.  10/05/09 Received PCP medical records which included Neuro consults of 1998. FINAL DX: Generalized tonic seizure disorder. Records reveal that patient initially experienced night time seizure activity 4/98 followed by vomiting x 1 w/congestion & cough but no fever.  Dx w/bronchitis & tx w/antibiotics.  After 2nd abnormal EEG, started on antiseizure meds & did well.  10/6/09 Received Neuro medical records of 10/2/09. FINAL DX: syncopal attacks, likely vagal; hx of generalized seizrue disorder in childhood, treated & idiopathic; dysmenorrhea.  Referred for EEG & if abnormal, an MRI.  No further medical records available.
about 15min p/vax pt began breaking out in large red blotchy patches that itched;started on lt leg & proceeded to trunk;no problem w/breathing & p/30min observation, nothing further devel;MD encouraged to use DPH & seek med attention immed;
within the first 30 minutes after taking the vax she felt nauseated and dizzy. She had a tingling sensation in her right hand.  Pt wanted the pharmacy to call 911.  EMS came and checked her vitals.  Her BP was 90/60 and then 90/70.  She was starting to feel better by this time so she was not taken to the hospital.
Noticed a little tingling & discomfort R arm a few days after rec. shot - then noticed muscle weakness R arm to extent I could not pick up my grandson like I normally do.
Per patient, left site feeling fine, after being monitored for 15 minutes per protocol. Claims he felt light headed, nervous, and blacked out and hit a car  in front of him. Per client, he was taken to the hospital and all tests came back clear. He later walked to another mini pod and reported the incident to them.
Pt. received 3 vaccines, (TDAP, HEP A and VZV). Immed. afterwards, client c/o nausea and became pale. Client was placed in supine position. BP 80/70 laying #2 BP 88/76 #3 BP sitting 88/70, BP 98/73 standing 98/78.
Within a month of getting the shots I started to develop shooting tingles and nerve discomfort in my left leg. Over the course of 6 months it started to spread throughout my legs. This is when I started pursuing help. I kept going to foot doctors until one finally told me it's neuropathy. I have been pursuing help with neurologist for 12 months now. I don't have answers. Symptoms include. Tingling, burning, shooting pain, weakness and loss of balance.
Red splotches appeared on face, scalp, neck, back, chest & shoulders approx 5 min p/vax red splotches faded approx 15mins p/admin of vax; pt went immediately to MD p/consult per phone;
tested positive for Covid; tested positive for Covid; This is a spontaneous report received from a contactable consumer (mothers friend). A 9-decade-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: Unknown) via an unspecified route of administration as dose 1, single and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: Unknown) via an unspecified route of administration as dose 2, single for Covid-19 immunization. Medical history and concomitant medications were not reported. Caller stated patient was a frail older woman and went to hospital for something and tested positive for covid. Caller was asking how she can be positive if she had had the 2 vaccines from Pfizer. Caller states she was not allowed to leave the hospital and go to a rehab centre to get the help she needed because she was positive. Caller declined to make a report and stated she needs to get herself taken care of first. Caller stated she does not have all of the information on her mothers friend. States she was concerned because patient was hospitalized and lives in the building her mother lives in. No further information provided to include NDC, lot or expiry dates. Patient was immunocompromised and cannot remember that she was exposed to anyone who was positive for Covid. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on unspecified date. The outcome of event was unknown.  No follow-up attempts are needed. No further information expected.
Left shoulder pain, along with shoulder stiffness; progressed throughout the day. Suspect bleed at site of vaccination. Treated with factor infusion of RECOMBINATE 1480 IU vials x2 given IV push x1.
Huge red rash around my entire bicep, fatigue, severe headache that developed into migraine, entire body aches, chills, hot flashes and sweating for four days. Flu like feeling and symptoms
1/20/21 at approximately 10:00 PM- low-grade fever (99.5-101.3), headache, body aches, joint aches, chills (teeth chattering), nausea (vomited x1), thirsty, loss of appetite, fatigue & weakness, slight nasal congestion  1/21/21 at approximately 11:00 AM started  taking Tylenol (cold & flu)  Q4 hrs 1/22/21 symptoms mostly subsided by 08:30 AM when I awoke.  Only intermittent headaches with low grade fever (99.1-99.3) 1/23/- 1/26/21 still with intermittent headaches, no fever
she had a sore arm and it was achy for 1/2 a day; This is a spontaneous report from a contactable consumer.  A 66-years-old female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PNEUMOCOCCAL 13-VAL CONJ VAC (DIPHT CRM197 PROTEIN)) , via an unspecified route of administration in 2016  at single dose for immunisation .  The patient medical history and concomitant medications were not reported.  The patient experienced a sore arm and it was achy for half a day on an unspecified date with outcome of unknown.  The reported event was non serious.  The information on the batch number has been requested.  Pfizer is a marketing authorization holder of [Pneumococcal 13-Val Conj Vac (Dipht CRM197 Protein)] in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of Pneumococcal 13-Val Conj Vac (Dipht CRM197 Protein) has submitted the same report to the regulatory authorities.
BURNING SENSATION ON THE BACK OF THE THROAT; ACHE IN JOINTS; LOW GRADE FEVER; MUSCLE ACHES; VERTIGO; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and expiry: UNKNOWN) dose was not reported, administered on 11-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the subject experienced vertigo. On 12-MAR-2021, the subject experienced burning sensation on the back of the throat. On 12-MAR-2021, the subject experienced ache in joints. On 12-MAR-2021, the subject experienced low grade fever. On 12-MAR-2021, the subject experienced muscle aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the vertigo, low grade fever, ache in joints, muscle aches and burning sensation on the back of the throat was not reported. This report was non-serious.
Child received vaccines (5 shots), cried, held his breath and turned blue, shaking. The administering nurse called a code blue, the team arrived, child recovered spontaneously and was taken to ER for observation.
Patient stated her face was feeling itching and was hot. Patients face was red and warm to touch. Patient was given 10mg of oral cetirizine. Patient observed for 30 minutes in observation area. Patient went home with spouse, stated she was feeling better. Redness in face resolved.
I had a seizure when I got out of bed to let out a dog at 2:30 AM.  I had a second seizure on March 2nd.  I had a CT scan of my brain. I go back to the doctor on the 28th of March for more tests, which are unknown at this time. He will tell me what I need at that appointment. He prescribed me Keppra.   Listed are the  3 shots in the series. If dates are needed let me know. I obviously didn't have all 3 vaccines on the same date. After the booster, given in September, I had a seizure in February.
Headache stomach ache  congestion myalgias arthrslgias most of the side effects luster degree of discomfort was worse than covid disease symptoms which means could barely get out off bed whoop score was less than 1%
after 10 min the pt complained of itching roof of the mouth; administered 50mg of Diphenhydramine; called 911; EMTs evaluated; pt decided not to go to ER; mother came to sit with pt and drive her home; after being at the rxcy for 1 hour she went home. Pt woke the next am with symptoms (throat swelling) and called allergist who sent her to the ER ASAP. she received treatment there and is doing fine now.
After vaccine felt electrical sensation/muscle spasm in shoulder, neck & back. Mentally "not clear" chills/fever 102 degrees. Next day weak - but only slept 3 hrs due to increased temp 102 degrees - took ibuprofen. Decreased fever. 3rd day continued fever 100 degrees. 4th day, no fever but "drained".
Had the flu that was treated with Zithromax. Follow up 02/15/05: Information on manufacturer and lot number of vaccine not available, vaccinated at another facility.
After several hours after receiving vaccine pt said he felt feverish and shaky. He then went to emergency rm.
Became lethargic, and spiked a fever about two hours later. Had pox like rash over his body, ongoing to at least the next day.
No adverse event; BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022) and NO ADVERSE EVENT (No adverse event) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (BUD was reported as 23-Dec-2021 and vaccine was administered on 09-Mar-2022).    Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received contains additional no new information was received.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704416:Master case
SLEEP APNEA 11/20/2021  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Pt. walked into clinic C/O redness, itching, and swollen, triaged by RN. Pt. scheduled appointment, left before she could be seen. Appointment rescheduled and patient did not come in to scheduled appointment. When calling to reschedule patient stated site is no longer swollen or red. Just itching. Declined to make appointment at that time, would call back if needed. Follow up calls made with no response, along with letter sent to home.
Within 24 hours of receiving flu vaccine. Developed severe sore throat, elevated temp for 3.5 days hoarsness; severe back and hip/pelvic pain. Most symptoms continued for 1 week.
first dose of Shingrix more than six months prior; soreness at the site of injection; redness, and swelling at the site of injection; swelling at the site of injection; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 74-year-old female patient who received Herpes zoster (Shingrix) (batch number J4D5J, expiry date 8th February 2021) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 11th August 2018, the patient received the 1st dose of Shingrix .5 ml. On an unknown date, the patient received the 2nd dose of Shingrix. In August 2018, less than a day after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced injection site pain, injection site erythema and injection site swelling. On an unknown date, the patient experienced incomplete course of vaccination. Shingrix was continued with no change. On an unknown date, the outcome of the injection site pain, injection site erythema and injection site swelling were recovering/resolving and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the injection site pain, injection site erythema and injection site swelling to be related to Shingrix.  Additional details were provided as follows: On 11th August 2018, within 24 hours after administration, the patient experienced soreness, redness, and swelling at the site of injection, resolving after an unknown time.  The patient received their 1st dose of Shingrix more than six months prior. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete vaccination schedule. Limited information was available. The reporter did not consent to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020145690:same reporter
Pt developed an erythematous plaque at injection site of DTAP and IPV. Pt treated with prednisone x 5 days and prophylactic Keflex. Follow-up 24 hrs later indicated a 50% reduction in size of lesion. MD believes it was a panniculitis due to ice cube applied by aunt after administration of DTAP.
Pt received vaccine on Friday, March 19th.  On Monday, March 23rd, t was hiking with boy scout troop, became short of breath, collapsed and went into full arrest.  BLS done on scene, transported to local ER where pt was pronounced dead.